AI-powered search

On-Demand CME Videos

Non-Steroidal Topical Therapies in Psoriasis and Atopic Dermatitis: The Paradigm Shift: Online CME Activity

About

Non-Steroidal Topical Therapies in Psoriasis and Atopic Dermatitis: The Paradigm Shift: Online CME Activity

This activity is supported by an educational grant from Dermavant Sciences, Inc.

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

March 27, 2024

Expiration Date:

April 1, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Identify non-steroidal topical agents for the treatment of atopic dermatitis and psoriasis

  • Discuss strategies to individualize care with topical non-steroidal therapies for the management of atopic dermatitis and psoriasis

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
G. Michael
G. Michael Lewitt, MD

Illinois Dermatology Institute - Partner
DeNova Research - Director of Medical Dermatology Research
Associate Professor Dermatology Rosalind
Franklin - Chicago Medical School
Chicago, IL

Linda
Linda Stein Gold, MD

Director Clinical Research 
Henry Ford Health System 
Detroit, MI

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

G. Michael Lewitt, MD

Advisory Board: Dermavant, Pfizer, Galderma, Janssen, Lilly, UCB Grant/Research Support: Amgen, Abbvie, Lilly, DermTech, Dermavant, Aobiome, Novan 

Consultant: Dermavant, Pfizer, Galderma, Janssen, Lilly, UCB Speakers’ Bureau or Honoraria: Abbvie, Arcutis, Lilly, Janssen, Pfizer, Dermavant, BMS, Incyte, UCB, Orthodermatologics

Linda F. Stein Gold, MD

Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved